Literature DB >> 23568576

Optimising treatment of refractory schizophrenia.

Katherine Beck, Oliver Howes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23568576     DOI: 10.1007/s00213-013-3076-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  7 in total

1.  Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993.

Authors:  A Breier; R W Buchanan; D Irish; W T Carpenter
Journal:  Psychiatr Serv       Date:  2000-10       Impact factor: 3.084

2.  Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia.

Authors:  Michele Fabrazzo; Silvestro La Pia; Palmiero Monteleone; Giuseppina Esposito; Antonio Pinto; Luigi De Simone; Rachele Bencivenga; Mario Maj
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

3.  A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

Authors:  H Y Meltzer; B Bastani; K Y Kwon; L F Ramirez; S Burnett; J Sharpe
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.

Authors:  Arsime Demjaha; Robin M Murray; Philip K McGuire; Shitij Kapur; Oliver D Howes
Journal:  Am J Psychiatry       Date:  2012-11       Impact factor: 18.112

5.  Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.

Authors:  J A Lieberman; A Z Safferman; S Pollack; S Szymanski; C Johns; A Howard; M Kronig; P Bookstein; J M Kane
Journal:  Am J Psychiatry       Date:  1994-12       Impact factor: 18.112

Review 6.  Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?

Authors:  Gary Remington; Ofer Agid; George Foussias; Larissa Ferguson; Krysta McDonald; Valerie Powell
Journal:  Psychopharmacology (Berl)       Date:  2012-11-22       Impact factor: 4.530

7.  Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.

Authors:  Oliver D Howes; Francis Vergunst; Siobhan Gee; Philip McGuire; Shitij Kapur; David Taylor
Journal:  Br J Psychiatry       Date:  2012-09-06       Impact factor: 9.319

  7 in total
  3 in total

1.  Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.

Authors:  Samantha A Hollingworth; Karl Winckel; Nargess Saiepour; Amanda J Wheeler; Nicholas Myles; Dan Siskind
Journal:  Psychopharmacology (Berl)       Date:  2018-03-27       Impact factor: 4.530

Review 2.  Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Authors:  Oliver D Howes; Rob McCutcheon; Ofer Agid; Andrea de Bartolomeis; Nico J M van Beveren; Michael L Birnbaum; Michael A P Bloomfield; Rodrigo A Bressan; Robert W Buchanan; William T Carpenter; David J Castle; Leslie Citrome; Zafiris J Daskalakis; Michael Davidson; Richard J Drake; Serdar Dursun; Bjørn H Ebdrup; Helio Elkis; Peter Falkai; W Wolfgang Fleischacker; Ary Gadelha; Fiona Gaughran; Birte Y Glenthøj; Ariel Graff-Guerrero; Jaime E C Hallak; William G Honer; James Kennedy; Bruce J Kinon; Stephen M Lawrie; Jimmy Lee; F Markus Leweke; James H MacCabe; Carolyn B McNabb; Herbert Meltzer; Hans-Jürgen Möller; Shinchiro Nakajima; Christos Pantelis; Tiago Reis Marques; Gary Remington; Susan L Rossell; Bruce R Russell; Cynthia O Siu; Takefumi Suzuki; Iris E Sommer; David Taylor; Neil Thomas; Alp Üçok; Daniel Umbricht; James T R Walters; John Kane; Christoph U Correll
Journal:  Am J Psychiatry       Date:  2016-12-06       Impact factor: 18.112

Review 3.  Clozapine: a review of clinical practice guidelines and prescribing trends.

Authors:  Stephanie Warnez; Silvia Alessi-Severini
Journal:  BMC Psychiatry       Date:  2014-04-07       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.